More on BIIB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-34.2% Growth)
- Ratings (6.4 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/30/26 *Est.)
- M&A (12/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Biogen (NQ:BIIB)
Delayed: 210.92 +2.05 (0.98%)
Prev. Close $208.87  
Open$212.98 
52 Wk High$333.65 
52 Wk Low$223.02 
Day High$215.61 
Day Low$208.79 
P/E 27.01  
EPS$7.81 
Volume335,753 

Friends, Peers and Foes (?): STOK, IONS, APLS, ALNY, LLY (more...)

Aug 13, 2026 09:26 AM Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Aug 13, 2026 05:38 AM Wolfe Research Upgrades Biogen (BIIB) to Outperform
Aug 12, 2026 04:51 PM Form 3 BIOGEN INC. For: Aug 03 Filed by: Parini Michael
Aug 6, 2026 06:15 PM Biogen completes acquisition of RayThera in immunology push
Aug 6, 2026 06:15 PM Biogen Completes Acquisition of RayThera Inc.
Aug 6, 2026 10:18 AM Form SCHEDULE 13G/A BIOGEN INC. Filed by: FMR LLC
Aug 5, 2026 04:04 PM Form 4 BIOGEN INC. For: Aug 03 Filed by: Minor Lloyd
Aug 5, 2026 08:00 AM Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Aug 4, 2026 11:23 AM Form 144 BIOGEN INC. Filed by: Minor Lloyd
Aug 4, 2026 06:39 AM Biogen (BIIB) PT Raised to $241 at Mizuho
View All Articles

Entities mentioned with BIIB

View All Entities